VeChain Slips 0.3% to $0.01838 - Key Analysis for VET Traders

VeChain's VET token has dropped 0.30% over the past hour to trade at $0.01838. With a market cap of $1.35 billion, VET remains a top 50 cryptocurrency.

Looking at the data, VET has fallen 4.65% over the past 24 hours. The 7-day decline stands at 4.86%, while the monthly drop is smaller at 1.58%. However, VET is down 20.28% over the past 6 months, indicating prolonged bearish momentum.

The hourly 0.30% dip shows sellers remain in control of price action for now. Support may emerge around $0.018, with resistance at $0.019.

What Key Levels Should VET Traders Watch?

On the downside, VET has initial support around $0.018. Below that, the 2022 low near $0.017 comes into focus.

On the upside, resistance is seen around $0.019 (weekly highs), then at $0.021 (2022 highs). A daily close above $0.021 would signal a bullish breakout.

Is VeChain a Good Buy at Current Prices?

VET remains deep in a long-term downtrend, which makes the token unlikely to see significant buying interest in the short-term. Aggressive traders may attempt longs near $0.018 support, but likely with tight stops.

Conservative traders will want to see a break above the downtrend line around $0.021 before anticipating a change in trend. Until then, rallies are likely temporary within the broader downtrend.

In summary, VeChain shows no signs of meaningful reversal yet, remaining in a firmly bearish long-term trend. Traders may find short-term trades in oversold bounces, but key resistance near $0.021 would need to break to signal a bullish shift in momentum.

Read more

GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee

GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee

NEW YORK, United States, July 18th, 2025, Chainwire GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) (“MEI”), in which it will serve as both strategic advisor and digital asset treasury manager. The $100 million private investment in public

By John Williams